Latest filing published 13 Nov 2025 for Metsera, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Clive Meanwell: trading record in brief
Clive Meanwell is a declared insider at 5 companies; the most frequent names are Medicines Co /DE, Endo Pharmaceuticals Holdings Inc and Metsera, Inc. Between 14 February 2006 and 13 November 2025, the trades on record add up to 182 filings.
In open-market terms, that means 3 purchases worth €180k on one side and 72 sales worth €30.1M on the other. The net balance comes to €30.0M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 46 share grants and 35 option exercises.
A typical purchase (the median) is worth €43k.
On 13 November 2025 came the latest disclosure, a transaction in Metsera, Inc. The clock since the last published purchase (25 August 2021) now reads 1,901 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Clive Meanwell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,767,462 sharesCommon StockSEC:0001193125-25-280795:1
- 5,375 sharesCommon StockSEC:0001193125-25-280795:0
- 277,890 sharesCommon StockSEC:0000950170-24-012842:0
- 11,300 shares@ US$9.8068.9% of flowClass A Ordinary SharesSEC:0000899243-21-034190:1Canonical exit: 22 Nov 2021 (T+90)
- 5,100 shares@ US$9.79100.0% of flowClass A Ordinary SharesSEC:0000899243-21-034190:0Canonical exit: 22 Nov 2021 (T+90)
- 480,340 sharesCommon StockSEC:0000950142-20-000045:0
- 60,000 shares@ US$7.311.0% of flowCommon StockSEC:0000950142-19-002600:0
- 15,620 shares@ US$13.540.5% of flowCommon StockSEC:0000950142-19-002600:1
- 240,000 shares@ US$17.459.5% of flowCommon StockSEC:0000950142-19-002600:2
- 150,000 shares@ US$22.047.5% of flowCommon StockSEC:0000950142-19-002600:3
- 64,568 shares@ US$31.494.6% of flowCommon StockSEC:0000950142-19-002600:4
- 11,483 shares@ US$30.550.8% of flowCommon StockSEC:0000950142-19-002600:5
- 329,796 shares@ US$84.7863.1% of flowCommon StockSEC:0000950142-19-002600:6
- 22,345 shares@ US$84.784.3% of flowCommon StockSEC:0000950142-19-002600:7
- 491 shares@ US$21.600.0% of flowCommon StockSEC:0001179110-19-010062:0
- 2,796 shares@ US$30.480.2% of flowCommon StockSEC:0001179110-19-005217:0
- 3,063 shares@ US$25.530.2% of flowCommon StockSEC:0001179110-19-003472:0
- 3,586 shares@ US$25.530.2% of flowCommon StockSEC:0001179110-19-003472:1
- 2,962 shares@ US$25.530.2% of flowCommon StockSEC:0001179110-19-003472:2
- 317 shares@ US$20.970.0% of flowCommon StockSEC:0001179110-19-003030:0
- 375 shares@ US$28.280.0% of flowCommon StockSEC:0001182489-18-000381:0
- 50,000 shares@ US$39.313.5% of flowCommon StockSEC:0001182489-18-000381:1
- 50,000 shares@ US$39.243.5% of flowCommon StockSEC:0001179110-18-010174:0
- 50,000 shares@ US$36.073.2% of flowCommon StockSEC:0001179110-18-009496:0
- 22,589 shares0Common StockSEC:0001179110-18-005903:0
25 of 178 declarations
